Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
Efficacy and Safety Study of SyB L-0501 in Combination With Rituximab in Patients With Untreated, Low-grade B Cell Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma
ClinicalTrials.gov study NCT01718691. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06018129. IPD Sharing: NO. Countries: 2. Publications: 0.
Trial of Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD) in Patients With Relapsed Non-Hodgkins Lymphoma
ClinicalTrials.gov study NCT00166439. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and PK/PD of TG-0054 in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients
ClinicalTrials.gov study NCT01018979. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Avastin (Bevacizumab) Plus Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD) for Advanced Stage Hodgkin Lymphoma
ClinicalTrials.gov study NCT00722865. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy
ClinicalTrials.gov study NCT01232556. IPD Sharing: YES. Countries: 25. Publications: 0.
Sorafenib Tosylate in Treating Patients With Recurrent Aggressive Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00131937. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00003499. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of TAK-659 in Combination With Venetoclax for Adult Participants With Previously Treated Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT03357627. IPD Sharing: YES. Countries: 3. Publications: 0.
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
ClinicalTrials.gov study NCT06377566. IPD Sharing: YES. Countries: 1. Publications: 0.
Dose-escalation Study of Oral Administration of S 55746 in Patients With Chronic Lymphocytic Leukaemia and B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02920697. IPD Sharing: YES. Countries: 8. Publications: 0.
A Phase 1b Open-Label Study Investigating the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT02961881. IPD Sharing: YES. Countries: 6. Publications: 0.
A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Relapsed/ Refractory B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06392477. IPD Sharing: YES. Countries: 5. Publications: 0.
Mocetinostat (MGCD0103) Plus Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Hodgkin Lymphoma
ClinicalTrials.gov study NCT02429375. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Nivolumab Plus Brentuximab Vedotin Versus Brentuximab Vedotin Alone in Patients With Advanced Stage Classical Hodgkin Lymphoma, Who Are Relapsed/ Refractory or Who Are Not Eligible for Auto
ClinicalTrials.gov study NCT03138499. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11)
ClinicalTrials.gov study NCT05008224. IPD Sharing: YES. Countries: 11. Publications: 0.
Fludarabine, Velcade and Rituximab for Relapsed or Refractory Follicular Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01186458. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Avastin Plus Rituximab for Patients With B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00081861. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Evaluating Safety and Tolerability of Inotuzumab Ozogamicin (CMC-544) in Japanese Patients With B-cell Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT00717925. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Study of MabThera (Rituximab) in Patients With Advanced Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00269113. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.